Ben Bonifant and Keith Kelly
Payors' increased power to restrict access and contract for reduced prices – combined with the growing use of evidence-based medicine to influence reimbursement policy – can profoundly impact potential revenues...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?